The report found that even with the Inflation Reduction Act's new $2,000 cap on Medicare Part D out-of-pocket prescription drug spending in 2025, retirees may still need substantial savings to cover premiums and other health care costs.

The case could affect what self-insured employers with a specific plan summary provision pay for care.

The latest polling from KFF shows that about 4 in 10 U.S. adults (41%) say it is likely the Trump administration's policies will lower prescription drug costs for people like them, but views generally follow party lines.